Interview with Dexcom’s CEO Terry Gregg
August 11, 2014- Interviewed by Steven E. Greer, MD
Above, in Part 1 of our interview with the CEO of Dexcom, Terry Gregg, we review the business model and products. Mr. Gregg explains how continuous glucose monitoring is safer than finger-stock monitoring.
In Part 2 of the interview, we discuss the bionic pancreas programs underway in academia, and why the Dexcom CGM is the chosen device in most of them.
In Part 3 of the interview, we discuss the financial status of Dexcom. We also go over in more detail the pipeline, and how Apple Computer will be a major partner for Dexcom.
Boston University, Diabetes, Endocrinology, FDA, Medical Devices | apples49 | 
July 27, 2015 1:19 am
No Comments
No comments yet.
Notice: comments_rss_link is deprecated since version 2.5! Use post_comments_feed_link() instead. in /data/30/1/121/80/1121895/user/1185656/htdocs/wordpress/wp-includes/functions.php on line 3406
RSS feed for comments on this post.
